Comparing the osteogenic potential of bone marrow and tendon‐derived stromal cells to repair a critical‐sized defect in the rat femur. (29th October 2015)

• Record Type: Journal Article
• Authors: Kunkel, Nadja; Wagner, Andrea; Gehwolf, Renate; Heimel, Patrick; Tempfer, Herbert; Korntner, Stefanie; Augat, Peter; Resch, Herbert; Redl, Heinz; Betz, Oliver; Bauer, Hans‐Christian; Traweger, Andreas
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 11:Number 7(2017)
• Page Start: 2014
• Page End: 2023
• Publication Date: 2015-10-29
• Subjects: tendon‐derived stromal cells -- bone tissue engineering -- segmental critical‐sized bone defect -- bone marrow stromal cells -- collagen scaffold; Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.2097
• Languages: English
• ISSNs: 1932-6254

Abstract

Abstract: Despite significant advancements in bone tissue‐engineering applications, the clinical impact of bone marrow stromal cells (BMSCs) for the treatment of large osseous defects remains limited. Therefore, other cell sources are under investigation for their osteogenic potential to repair bone. In this study, tendon‐derived stromal cells (TDSCs) were evaluated in comparison to BMSCs to support the functional repair of a 5 mm critical‐sized, segmental defect in the rat femur. Analysis of the trilineage differentiation capacity of TDSCs and BMSCs cultured on collagen sponges revealed impaired osteogenic differentiation and mineral deposition of TDSCs in vitro, whereas chondrogenic and adipogenic differentiation was evident for both cell types. Radiographic assessment demonstrated that neither cell type significantly improved the healing rate of a challenging 5 mm segmental femoral defect. Transplanted TDSCs and BMSCs both led to the formation of only small amounts of bone in the defect area, and histological evaluation revealed non‐mineralized, collagen‐rich scar tissue to be present within the defect area. Newly formed lamellar bone was restricted to the defect margins, resulting in closure of the medullary cavity. Interestingly, in comparison to BMSCs, significantly more TDSC‐derived cells were present at the osteotomy gap up to 8 weeks after transplantation and were also found to be located within newly formed lamellar bone, suggesting their capacity to directly contribute to de novo bone formation. To our knowledge, this is the first study investigating the in vivo capacity of TDSCs to regenerate a critical‐sized defect in the rat femur. Copyright © 2015 John Wiley & Sons, Ltd.